The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate.

dc.contributor.authorCem, Onal
dc.contributor.authorSedef, Ali Murat
dc.contributor.authorKose, Fatih
dc.contributor.authorOymak, Ezgi
dc.contributor.authorGuler, Ozan Cem
dc.contributor.authorSumbul, Ahmet Taner
dc.contributor.authorAksoy, Sercan
dc.contributor.authorYildirim, Berna Akkus
dc.contributor.authorBesen, Ali Ayberk
dc.contributor.authorMullaoglu, Sadik
dc.contributor.authorMertsoylu, Huseyin
dc.contributor.authorOzyigit, Gokhan
dc.contributor.orcID0000-0001-6908-3412en_US
dc.contributor.researcherIDD-4793-2014en_US
dc.contributor.researcherIDAAC-5654-2020en_US
dc.date.accessioned2020-11-02T07:26:44Z
dc.date.available2020-11-02T07:26:44Z
dc.date.issued2019
dc.description.sponsorshipASCO; SITCen_US
dc.identifier.issn0732-183Xen_US
dc.identifier.issue7en_US
dc.identifier.urihttp://hdl.handle.net/11727/4987
dc.identifier.volume37en_US
dc.identifier.wos000489108800349en_US
dc.language.isoengen_US
dc.relation.isversionof10.1200/JCO.2019.37.7_suppl.308en_US
dc.relation.journalJOURNAL OF CLINICAL ONCOLOGYen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleThe hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate.en_US
dc.typeconferenceObjecten_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: